Intraperitoneal and intravenous paclitaxel plus S-1 versus intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis: Results from the multicenter, randomized, phase 3 DRAGON-01 trial.

被引:1
|
作者
Yang, Zhongyin
Shi, Zheng
Lu, Sheng
Shi, Min
Nie, Mingming
Chen, Jian
Wu, Dan
Mou, Yiping
Xu, Yunyun
Wang, Yanong
Liu, Xiaowen
Cao, Hui
Gu, Jiayi
Yu, Jiren
Liu, Kai
Liu, Xinchun
Zhang, Jun
Yin, Kai
Zhu, Zhenggang
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China
[2] Changhai Hosp Shanghai, Shanghai, Peoples R China
[3] Second Affiliated Hosp Zhejiang Univ Sch Med, Hangzhou, Peoples R China
[4] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China
[5] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai, Peoples R China
[7] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
[8] Shandong Univ, Shandong Canc Hosp, Jinan, Peoples R China
[9] Westlake Univ, Affiliated Hangzhou Peoples Hosp 1, Sch Med, Hangzhou, Peoples R China
关键词
D O I
10.1200/JCO.2025.43.4_suppl.327
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:327 / 327
页数:1
相关论文
共 50 条
  • [1] S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis
    Kitayama, J.
    Ishigami, H.
    Yamaguchi, H.
    Yamashita, H.
    Emoto, S.
    Kaisaki, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 264 - 264
  • [2] Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
    Ishigami, Hironori
    Fujiwara, Yoshiyuki
    Fukushima, Ryoji
    Nashimoto, Atsushi
    Yabusaki, Hiroshi
    Imano, Motohiro
    Imamoto, Haruhiko
    Kodera, Yasuhiro
    Uenosono, Yoshikazu
    Amagai, Kenji
    Kadowaki, Shigenori
    Miwa, Hiroto
    Yamaguchi, Hironori
    Yamaguchi, Takuhiro
    Miyaji, Tempei
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1922 - +
  • [3] Intraperitoneal Paclitaxel Combined With S-1 Plus Intravenous Paclitaxel for Gastric Cancer With Peritoneal Metastasis - a Report of 100 Cases
    Ishigami, H.
    Kaisaki, S.
    Yamaguchi, H.
    Yamashita, H.
    Emoto, S.
    Kitayama, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S449 - S449
  • [4] S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis: A report of 100 cases.
    Ishigami, H.
    Kaisaki, S.
    Yamaguchi, H.
    Yamashita, H.
    Emoto, S.
    Nagawa, H.
    Kitayama, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Phase III study comparing intraperitoneal paclitaxel plus S-1/paclitaxel with S-1/cisplatin in gastric cancer patients with peritoneal metastasis: PHOENIX-GC trial
    Fujiwara, Y.
    Ishigami, H.
    Fukushima, R.
    Nashimoto, A.
    Yabusaki, H.
    Imamoto, H.
    Imano, M.
    Kodera, Y.
    Uenosono, Y.
    Amagai, K.
    Kadowaki, S.
    Miwa, H.
    Yamaguchi, H.
    Yamaguchi, T.
    Kitayama, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Phase III study of intraperitoneal paclitaxel plus s-1/paclitaxel compared with s-1/cisplatin in gastric cancer patients with peritoneal metastasis: PHOENIX-GC trial
    Ishigami, Hironori
    Fujiwara, Yoshiyuki
    Fukushima, Ryoji
    Nashimoto, Atsushi
    Yabusaki, Hiroshi
    Imamoto, Haruhiko
    Imano, Motohiro
    Kodera, Yasuhiro
    Uenosono, Yoshikazu
    Amagai, Kenji
    Kadowaki, Shigenori
    Miwa, Hiroto
    Yamaguchi, Takuhiro
    Yamaguchi, Hironori
    Watanabe, Toshiaki
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis
    Yamaguchi, Hironori
    Kitayama, Joji
    Ishigami, Hironori
    Emoto, Shigenobu
    Yamashita, Hiroharu
    Watanabe, Toshiaki
    CANCER, 2013, 119 (18) : 3354 - 3358
  • [8] Weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis
    Ishigami, H.
    Kitayama, J.
    Kaisaki, S.
    Hidemura, A.
    Kato, M.
    Otani, K.
    Kamei, T.
    Soma, D.
    Miyato, H.
    Nagawa, H.
    EJC SUPPLEMENTS, 2009, 7 (02): : 368 - 368
  • [9] Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)
    Yamamoto, Tomohisa
    Fujii, Tsutomu
    Hirano, Satoshi
    Motoi, Fuyuhiko
    Honda, Goro
    Uemura, Kenichiro
    Kitayama, Joji
    Unno, Michiaki
    Kodera, Yasuhiro
    Yamaue, Hiroki
    Shimokawa, Toshio
    Hashimoto, Daisuke
    Yamaki, So
    Yoshitomi, Hideyuki
    Miura, Fumihiko
    Ueno, Hideki
    Sekimoto, Mitsugu
    Satoi, Sohei
    TRIALS, 2022, 23 (01)
  • [10] Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)
    Tomohisa Yamamoto
    Tsutomu Fujii
    Satoshi Hirano
    Fuyuhiko Motoi
    Goro Honda
    Kenichiro Uemura
    Joji Kitayama
    Michiaki Unno
    Yasuhiro Kodera
    Hiroki Yamaue
    Toshio Shimokawa
    Daisuke Hashimoto
    So Yamaki
    Hideyuki Yoshitomi
    Fumihiko Miura
    Hideki Ueno
    Mitsugu Sekimoto
    Sohei Satoi
    Trials, 23